全国细菌耐药监测网2020—2024年伤口及脓液标本细菌耐药监测报告
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R181.3+2

基金项目:


Antimicrobial resistance of bacteria from wound and pus specimens: surveillance report from China Antimicrobial Resistance Surveillance System, 2020-2024
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 文章评论
    摘要:

    目的 了解全国患者伤口及脓液标本分离细菌的分布及对临床常用抗菌药物的耐药情况。方法 应用WHONET 5.6软件统计分析全国细菌耐药监测网(CARSS)成员单位2020—2024年患者伤口及脓液标本分离细菌的药物敏感性检测数据,药敏试验结果依据美国临床实验室标准化协会(CLSI)标准判读。结果 2020—2024年CARSS成员单位伤口及脓液标本共分离细菌1 808 994株,居前5位的细菌依次为大肠埃希菌(28.5%)、金黄色葡萄球菌(18.9%)、肺炎克雷伯菌(10.1%)、铜绿假单胞菌(6.3%)、表皮葡萄球菌(3.1%)。2020—2024年,耐甲氧西林金黄色葡萄菌(MRSA)检出率从26.2% 降至24.9%(P<0.001);耐甲氧西林凝固酶阴性葡萄球菌(MRCNS)检出率从67.9% 降至64.9%(P<0.001),未检出耐万古霉素的葡萄球菌属细菌。粪肠球菌对多数抗菌药物的耐药率均低于屎肠球菌,但对利奈唑胺的耐药率高于屎肠球菌[(2.4%~3.4%)VS(0.6%~1.3%)]。大肠埃希菌对碳青霉烯类抗生素的敏感率>98%,对喹诺酮类、头孢吡肟、哌拉西林/他唑巴坦的耐药率上升(均P<0.05)。肺炎克雷伯菌对头孢他啶、头孢曲松、头孢噻肟、头孢吡肟、喹诺酮类和复方磺胺甲 口 恶 唑的耐药率均低于大肠埃希菌,对哌拉西林/他唑巴坦的耐药率升高(P<0.001),对其余抗菌药物的耐药率保持不变或降低。铜绿假单胞菌对哌拉西林、哌拉西林/他唑巴坦的耐药率升高(均P<0.001),对其余抗菌药物的耐药率降低或没有显著变化。鲍曼不动杆菌对氨苄西林/舒巴坦、头孢吡肟、庆大霉素、米诺环素的耐药率降低(均P<0.05),对左氧氟沙星的耐药率升高(P=0.012)。结论 伤口及脓液标本分离病原菌对抗菌药物的耐药情况依然严峻,应定期监测伤口及脓液分离细菌的分布和耐药性变迁,持续加强抗菌药物合理应用的监管,为临床经验治疗提供依据。

    Abstract:

    Objective To understand the distribution as well as antimicrobial resistance of bacteria isolated from wound and pus specimens of patients nationwide. Methods Data about antimicrobial susceptibility testing of bacteria isolated from wound and pus specimens from member hospitals of China Antimicrobial Resistance Surveillance System (CARSS) in 2020-2024 were analyzed using WHONET 5.6 software. Antimicrobial susceptibility testing results were interpreted according to American Clinical and Laboratory Standards Institute (CLSI). Results In 2020-2024, a total of 1 808 994 bacterial strains were isolated from wound and pus specimens from member hospitals of CARSS, with the top 5 bacteria being Escherichia coli (28.5%), Staphylococcus aureus (18.9%), Klebsiella pneumoniae (10.1%), Pseudomonas aeruginosa (6.3%) and Staphylococcus epidermidis (3.1%). In 2020-2024, detection rate of methicillin-resistant Staphylococcus aureus (MRSA) decreased from 26.2% to 24.9% (P<0.001); detection rate of methicillin-resistant coagulase negative Staphylococcus (MRCNS) decreased from 67.9% to 64.9%(P<0.001); vancomycin-resistant Staphylococcus were not found. The resistant rates of Enterococcus faecalis to most antimicrobial agents were all lower than Enterococcus faecium, but resistance rate to linezo-lid was higher than Enterococcus faecium ([2.4%-3.4%] vs [0.6%-1.3%]). The susceptibility rate of Escherichia coli to carbapenem antibiotics was >98%, resistance rates to quinolones, cefepime, and piperacillin/tazobactam increased (all P<0.05). Klebsiella pneumoniae showed lower resistance rates to ceftazidime,ceftriaxone, cefotaxime, cefepime, quinolones, and compound sulfamethoxazole than Escherichia coli, and increased resistance rates to piperacillin/tazobactam (P<0.001), while the resistance rates to other antimicrobial agents remained unchanged or decreased. The resistance rates of Pseudomonas aeruginosa to piperacillin and piperacillin/tazobactam increased (both P<0.001), while those to other antimicrobial agents decreased or showed no significant changes. The resis-tance rates of Acinetobacter baumannii to ampicillin/sulbactam, cefepime, gentamicin, and minocycline decreased (all P<0.05), while that to levofloxacin increased (P=0.012). Conclusion Antimicrobial resistance of pathoge-nic bacteria isolated from wound and pus specimens remains severe. It is necessary to regularly surveil the distribution and antimicrobial resistance changes of bacteria isolated from wound and pus specimens, and persistently strengthen the surveillance on rational use of antimicrobial agents, so as to provide basis for clinical empiric treatment.

    参考文献
    相似文献
引用本文

全国细菌耐药监测网.全国细菌耐药监测网2020—2024年伤口及脓液标本细菌耐药监测报告[J]. 中国感染控制杂志,2025,24(12):1772-1784. DOI:10.12138/j. issn.1671-9638.20255420.
China Antimicrobial Resistance Surveillance System. Antimicrobial resistance of bacteria from wound and pus specimens: surveillance report from China Antimicrobial Resistance Surveillance System, 2020-2024[J]. Chin J Infect Control, 2025,24(12):1772-1784. DOI:10.12138/j. issn.1671-9638.20255420.

复制
分享
文章指标
  • 摘要阅读次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2025-10-05
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-12-31
  • 出版日期: 2025-12-28